MedPath
HSA Approval

LENALIDOMIDE GRINDEKS HARD CAPSULE 25MG

SIN17157P

LENALIDOMIDE GRINDEKS HARD CAPSULE 25MG

LENALIDOMIDE GRINDEKS HARD CAPSULE 25MG

January 2, 2025

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L04AX04

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

JOINT STOCK COMPANY GRINDEKS

Active Ingredients

Lenalidomide ammonium chloride equivalent to lenalidomide

25mg

Proparacaine

Documents

Package Inserts

Lenalidomide Grindeks Hard Capsules PI.pdf

Approved: April 25, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LENALIDOMIDE GRINDEKS HARD CAPSULE 25MG - HSA Approval | MedPath